S&P 500   3,669.01 (+0.18%)
DOW   29,883.79 (+0.20%)
QQQ   304.06 (+0.20%)
AAPL   123.14 (+0.34%)
MSFT   215.15 (-0.49%)
FB   287.52 (+0.34%)
GOOGL   1,828.38 (+1.84%)
AMZN   3,204.00 (-0.50%)
TSLA   564.20 (-3.52%)
NVDA   541.64 (+1.13%)
BABA   261.40 (-0.99%)
CGC   28.00 (+5.07%)
GE   10.41 (+2.56%)
MU   69.10 (+3.01%)
AMD   93.70 (+1.16%)
T   29.09 (+0.76%)
NIO   47.36 (+4.41%)
F   9.19 (-0.54%)
ACB   11.02 (+13.03%)
NFLX   503.43 (-0.23%)
BA   224.22 (+5.26%)
GILD   61.14 (+0.03%)
DIS   153.84 (+2.94%)
S&P 500   3,669.01 (+0.18%)
DOW   29,883.79 (+0.20%)
QQQ   304.06 (+0.20%)
AAPL   123.14 (+0.34%)
MSFT   215.15 (-0.49%)
FB   287.52 (+0.34%)
GOOGL   1,828.38 (+1.84%)
AMZN   3,204.00 (-0.50%)
TSLA   564.20 (-3.52%)
NVDA   541.64 (+1.13%)
BABA   261.40 (-0.99%)
CGC   28.00 (+5.07%)
GE   10.41 (+2.56%)
MU   69.10 (+3.01%)
AMD   93.70 (+1.16%)
T   29.09 (+0.76%)
NIO   47.36 (+4.41%)
F   9.19 (-0.54%)
ACB   11.02 (+13.03%)
NFLX   503.43 (-0.23%)
BA   224.22 (+5.26%)
GILD   61.14 (+0.03%)
DIS   153.84 (+2.94%)
S&P 500   3,669.01 (+0.18%)
DOW   29,883.79 (+0.20%)
QQQ   304.06 (+0.20%)
AAPL   123.14 (+0.34%)
MSFT   215.15 (-0.49%)
FB   287.52 (+0.34%)
GOOGL   1,828.38 (+1.84%)
AMZN   3,204.00 (-0.50%)
TSLA   564.20 (-3.52%)
NVDA   541.64 (+1.13%)
BABA   261.40 (-0.99%)
CGC   28.00 (+5.07%)
GE   10.41 (+2.56%)
MU   69.10 (+3.01%)
AMD   93.70 (+1.16%)
T   29.09 (+0.76%)
NIO   47.36 (+4.41%)
F   9.19 (-0.54%)
ACB   11.02 (+13.03%)
NFLX   503.43 (-0.23%)
BA   224.22 (+5.26%)
GILD   61.14 (+0.03%)
DIS   153.84 (+2.94%)
S&P 500   3,669.01 (+0.18%)
DOW   29,883.79 (+0.20%)
QQQ   304.06 (+0.20%)
AAPL   123.14 (+0.34%)
MSFT   215.15 (-0.49%)
FB   287.52 (+0.34%)
GOOGL   1,828.38 (+1.84%)
AMZN   3,204.00 (-0.50%)
TSLA   564.20 (-3.52%)
NVDA   541.64 (+1.13%)
BABA   261.40 (-0.99%)
CGC   28.00 (+5.07%)
GE   10.41 (+2.56%)
MU   69.10 (+3.01%)
AMD   93.70 (+1.16%)
T   29.09 (+0.76%)
NIO   47.36 (+4.41%)
F   9.19 (-0.54%)
ACB   11.02 (+13.03%)
NFLX   503.43 (-0.23%)
BA   224.22 (+5.26%)
GILD   61.14 (+0.03%)
DIS   153.84 (+2.94%)
Log in
NASDAQ:KTWO

K2M Group Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$27.50
0.00 (0.00 %)
(As of 11/9/2018)
Add
Compare
Today's Range
$27.50
Now: $27.50
$27.50
50-Day Range N/A
52-Week Range
$16.44
Now: $27.50
$27.50
VolumeN/A
Average Volume1.85 million shs
Market Capitalization$1.20 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.43
K2M Group Holdings, Inc., a medical device company, provides spine and minimally invasive solutions in the United States and internationally. The company offers implants, disposables, and instruments primarily to hospitals for use by spine surgeons to treat spinal pathologies, such as deformity, trauma, and tumor. Its complex spine products include EVEREST, MESA, and MESA 2 deformity spinal systems; NILE alternative and proximal fixation spinal systems; MESA rail deformity spinal systems; Cricket spinal correction rod reduction instrumentation; CAPRI corpectomy cage systems; MESA small stature, rail small stature, and mini spinal systems; SERENGETI complex spine minimally invasive retractor systems; RAVINE complex spine lateral access systems; SANTORINI corpectomy cage systems; YUKON OCT spinal systems; and PALO ALTO cervical static corpectomy cage systems. The company's minimally invasive surgery products consist of EVEREST minimally invasive spinal and XT spinal, SERENGETI minimally invasive retractor, MOJAVE PL 3D expandable interbody, RAVINE lateral access, CASCADIA lateral 3D interbody, ALEUTIAN lateral interbody, and TERRA NOVA minimally invasive access systems. In addition, its degenerative spine products comprise EVEREST degenerative spinal, CASCADIA and ALEUTIAN interbody, SAHARA AL expandable stabilization, RHINE cervical disc, CHESAPEAKE interbody, PYRENEES cervical plate, and BLUE RIDGE hybrid cervical plate systems. Further, the company provides Balance ACS, a platform that includes tools to assist surgeons with obtaining authorization from healthcare insurers. K2M Group Holdings, Inc. markets and sells its products through direct sales employees, independent sales agencies, and distributor partners. The company was founded in 2004 and is headquartered in Leesburg, Virginia.
K2M Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.69 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:KTWO
CUSIPN/A
Phone703-777-3155
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$258.03 million
Book Value$5.59 per share

Profitability

Net Income$-37,140,000.00

Miscellaneous

Market Cap$1.20 billion
Next Earnings DateN/A
OptionableOptionable

Receive KTWO News and Ratings via Email

Sign-up to receive the latest news and ratings for KTWO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











K2M Group (NASDAQ:KTWO) Frequently Asked Questions

What stocks does MarketBeat like better than K2M Group?

Wall Street analysts have given K2M Group a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but K2M Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were K2M Group's earnings last quarter?

K2M Group Holdings, Inc. (NASDAQ:KTWO) announced its earnings results on Wednesday, August, 1st. The medical device company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.19) by $0.06. The medical device company had revenue of $73.58 million for the quarter, compared to the consensus estimate of $70.85 million. K2M Group had a negative net margin of 16.66% and a negative return on equity of 19.69%. K2M Group's revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.21) EPS.
View K2M Group's earnings history
.

Who are some of K2M Group's key competitors?

What other stocks do shareholders of K2M Group own?

Who are K2M Group's key executives?

K2M Group's management team includes the following people:
  • Mr. Eric D. Major, Co-Founder, Chairman, CEO & Pres (Age 48)
  • Dr. John Phillip Kostuik, Co-Founder, Chief Medical Officer & Director (Age 80)
  • Mr. Gregory S. Cole, Chief Financial Officer (Age 48)
  • Mr. Lane E. Major, Chief Operating Officer (Age 39)
  • Mr. Dave B. MacDonald, Sr. VP of Operations

What is K2M Group's stock symbol?

K2M Group trades on the NASDAQ under the ticker symbol "KTWO."

What is K2M Group's stock price today?

One share of KTWO stock can currently be purchased for approximately $27.50.

How big of a company is K2M Group?

K2M Group has a market capitalization of $1.20 billion and generates $258.03 million in revenue each year. The medical device company earns $-37,140,000.00 in net income (profit) each year or ($0.87) on an earnings per share basis.

What is K2M Group's official website?

The official website for K2M Group is www.k2m.com.

How can I contact K2M Group?

K2M Group's mailing address is 600 HOPE PARKWAY SE, LEESBURG VA, 20175. The medical device company can be reached via phone at 703-777-3155 or via email at [email protected]

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.